Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$49.38 - $63.75 $1,925 - $2,486
39 Added 1.02%
3,849 $240,000
Q3 2023

Nov 08, 2023

BUY
$48.64 - $62.51 $185,318 - $238,163
3,810 New
3,810 $214,000
Q1 2023

Apr 28, 2023

SELL
$52.6 - $67.34 $1,893 - $2,424
-36 Reduced 0.96%
3,697 $202,000
Q4 2022

Feb 01, 2023

BUY
$59.56 - $76.6 $222,337 - $285,947
3,733 New
3,733 $233,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Janney Capital Management LLC Portfolio

Follow Janney Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.